Lessee, Operating Lease, Liability, Undiscounted Excess Amount of Xilio Therapeutics, Inc. from 31 Dec 2021 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Xilio Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD history and change rate from 31 Dec 2021 to 31 Dec 2024.
  • Xilio Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 31 Dec 2024 was $1,843,000, a 27% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

Xilio Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $1,843,000 -$686,000 -27% 31 Dec 2024 10-K 11 Mar 2025 2024 FY
Q4 2023 $2,529,000 -$765,000 -23% 31 Dec 2023 10-K 01 Apr 2024 2023 FY
Q4 2022 $3,294,000 -$833,000 -20% 31 Dec 2022 10-K 02 Mar 2023 2022 FY
Q4 2021 $4,127,000 31 Dec 2021 10-K 01 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.